Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Molecules (Basel, Switzerland)|November 14, 2023
Double Attack to Oxidative Stress in Neurodegenerative Disorders: MAO-B and Nrf2 as Elected TargetsFilippo Basagni, Maria Luisa Di Paolo, Giorgio Cozza, et al.Antioxidants (Basel, Switzerland)|July 27, 2022
Nature-Inspired Hybrids (NIH) Improve Proteostasis by Activating Nrf2-Mediated Protective Pathways in Retinal Pigment Epithelial CellsAli Koskela, Federico Manai, Filippo Basagni, et al.Chemical Reviews|November 18, 2022
Radiosynthesis, Preclinical, and Clinical Positron Emission Tomography Studies of Carbon-11 Labeled Endogenous and Natural Exogenous CompoundsAntonio Shegani, Steven Kealey, Federico Luzi, et al.ACS Medicinal Chemistry Letters|November 17, 2022
Inhibition of β-Amyloid Aggregation in Alzheimer's Disease: The Key Role of (Pro)electrophilic WarheadsFilippo Basagni, Marina Naldi, Tiziana Ginex, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|March 5, 2019
Exploring the activity of polyamine analogues on polyamine and spermine oxidase: methoctramine, a potent and selective inhibitor of polyamine oxidaseMaria Luisa Di Paolo, Manuela Cervelli, Paolo Mariottini, et al.Molecules (Basel, Switzerland)|September 9, 2023
From Monoamine Oxidase Inhibition to Antiproliferative Activity: New Biological Perspectives for Polyamine AnalogsGiulia Nordio, Francesco Piazzola, Giorgio Cozza, et al.International Journal of Molecular Sciences|October 2, 2020
NRF2 and PPAR-γ Pathways in Oligodendrocyte Progenitors: Focus on ROS Protection, Mitochondrial Biogenesis and Promotion of Cell DifferentiationChiara De Nuccio, Antonietta Bernardo, Carmen Troiano, et al.European Journal of Medicinal Chemistry|July 14, 2019
Merging memantine and ferulic acid to probe connections between NMDA receptors, oxidative stress and amyloid-β peptide in Alzheimer's diseaseMichela Rosini, Elena Simoni, Roberta Caporaso, et al.Chemmedchem|July 29, 2026
Exploring Disulfide Bridge as a Tool to Improve Pioglitazone's Neuroprotective Potential: Toward the Development of Prolonged-Acting MAO-B/PPARγ ModulatorsFilippo Basagni, Maria Luisa Di Paolo, Antonio Laghezza, et al.Frontiers in Pharmacology|September 14, 2020
Targeting Cytokine Release Through the Differential Modulation of Nrf2 and NF-κB Pathways by Electrophilic/Non-Electrophilic CompoundsFrancesca Fagiani, Michele Catanzaro, Erica Buoso, et al.Pageof 3